The cortisol testing kits market is projected to grow from USD 208.6 million in 2025 to USD 373.0 million by 2035, at a CAGR of 6.0%. Elisa: Enzyme-Linked Immunosorbent Assay will dominate with a 32.5% market share, while chronic stress will lead the indication segment with a 40.1% share.